tiprankstipranks
Genmab A/S (GB:0MGB)
LSE:0MGB
UK Market
0MGB
Genmab A/S
RESEARCH TOOLSreports

Genmab A/S (0MGB) Income Statement

14 Followers

Genmab A/S Income Statement

Last quarter (Q4 2025), Genmab A/S's total revenue was kr1.07B, a decrease of -83.46% from the same quarter last year. In Q4, Genmab A/S's net income was kr31.21M. See Genmab A/S’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 3.86Bkr 21.53Bkr 16.47Bkr 14.60Bkr 8.48B
Gross Profit
kr 3.54Bkr 20.54Bkr 16.25Bkr 14.60Bkr 8.48B
Operating Expenses
kr 2.24Bkr 13.84Bkr 10.93Bkr 8.24Bkr 5.46B
Depreciation and Amortization
kr 73.67Mkr 413.00Mkr 327.00Mkr 362.00Mkr 250.00M
EBITDA
kr 1.37Bkr 9.70Bkr 5.99Bkr 7.33Bkr 4.18B
Operating Income
kr 1.30Bkr 6.70Bkr 5.32Bkr 6.27Bkr 2.95B
Other Income/Expenses
kr -47.73Mkr 2.46Bkr 316.00Mkr 678.00Mkr 965.00M
Pretax Income
kr 1.25Bkr 9.16Bkr 5.64Bkr 6.95Bkr 3.98B
Net Income
kr 999.19Mkr 7.84Bkr 4.35Bkr 5.45Bkr 2.96B
Per Share Metrics
Basic EPS
kr 16.08kr 122.21kr 66.64kr 83.38kr 46.00
Diluted EPS
kr 15.94kr 121.36kr 66.02kr 82.59kr 45.54
Weighted Average Shares Outstanding
 62.15M 64.63M 65.31M 65.39M 65.40M
Weighted Average Shares Outstanding (Diluted)
 62.69M 64.63M 65.92M 66.01M 66.05M
Currency in DKK

Genmab A/S Earnings and Revenue History